scholarly journals Micro-computed tomography analysis of gap and void formation in different prefabricated fiber post cementation materials and techniques

2019 ◽  
Vol 31 (2) ◽  
pp. 236-241
Author(s):  
Aws ArRejaie ◽  
Saleh A. Alsuliman ◽  
Mohammed O. Aljohani ◽  
Hesham A. Altamimi ◽  
Emad Alshwaimi ◽  
...  
2021 ◽  
Vol 27 (S1) ◽  
pp. 1028-1029
Author(s):  
Robert Palomino ◽  
Ke-Bin Low ◽  
Chunxin Ji ◽  
Ivan Petrovic ◽  
Florian Waltz ◽  
...  

2018 ◽  
Vol 32 (suppl 1) ◽  
Author(s):  
Manoel Damião de Sousa-Neto ◽  
Yara Correa Silva-Sousa ◽  
Jardel Francisco Mazzi-Chaves ◽  
Kleber Kildare Teodoro Carvalho ◽  
Ana Flávia Simões Barbosa ◽  
...  

2015 ◽  
Vol 39 (3) ◽  
pp. 187-191 ◽  
Author(s):  
Katharina Morant Holanda de Oliveira ◽  
Raquel Assed Bezerra da Silva ◽  
Erika Calvano Küchler ◽  
Alexandra Mussolino de Queiroz ◽  
Paulo Nelson Filho ◽  
...  

2015 ◽  
Vol 3 (3) ◽  
pp. 147-152 ◽  
Author(s):  
Paolo Fais ◽  
Chiara Giraudo ◽  
Alessia Viero ◽  
Alessandro Amagliani ◽  
Guido Viel ◽  
...  

2020 ◽  
Vol 23 (4) ◽  
Author(s):  
Fernanda Ferrari Esteves Torres ◽  
Juliane Maria Guerreiro-Tanomaru ◽  
Roberta Bosso-Martelo ◽  
Camila Galletti Espir ◽  
Jáder Camilo Pinto ◽  
...  

Author(s):  
Joshua Zhaojun Xian ◽  
Mimi Lu ◽  
Felicia Fong ◽  
Rong Qiao ◽  
Nikhil Rajesh Patel ◽  
...  

Objective: Statins lower cardiovascular event risk, yet, they paradoxically increase coronary artery calcification, a marker consistently associated with increased cardiovascular risks. As calcium deposits influence rupture risk due to stress from compliance mismatch at their surfaces, we hypothesized that statins may lower cardiovascular risk by altering the microarchitecture of calcium deposits. Thus, using mice with preexisting vascular calcification, we tested whether pravastatin reduces the mineral surface area of calcium deposits. Approach and Results: Aged Apoe − /− mice were treated with pravastatin or vehicle for 20 weeks. Aortic calcification was assessed by in vivo sodium fluoride labeled with fluoride 18 isotope-micro-positron emission tomography/micro-computed tomography imaging at weeks 0, 10, and 20 and by histomorphometry at euthanasia. Micro-computed tomography analysis showed that, in both groups, the amount of vascular calcification increased significantly over the 20-week period, but pravastatin treatment did not augment over the controls. In contrast, the micro-positron emission tomography analysis showed that, at week 10, the pravastatin group had less 18 F uptake, suggesting reduced surface area of actively mineralizing deposits, but this decrease was not sustained at week 20. However, a significant difference in the mineral deposit size was found by histomorphometry. The pravastatin group had significantly more aortic microcalcium deposits (<50 µm in diameter) than the controls. The pravastatin group also had more vascular cells positive for alkaline phosphatase activity than the controls. The amount of collagen and osteopontin, additional osteoblastic markers, were not significantly different between the 2 groups. Conclusions: These results suggest that pravastatin treatment alters the microarchitecture of aortic calcium deposits with potential effects on plaque stability.


Sign in / Sign up

Export Citation Format

Share Document